Asia-Pacific Insulin Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia-Pacific Insulin Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia-Pacific Insulin Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia-Pacific Insulin Market Regional Analysis

6.2 Asia-Pacific Insulin Market Revenue 2020-2028 (US$ Million)

6.3 Asia-Pacific Insulin Market Forecast Analysis

7. Asia-Pacific Insulin Market Analysis – by Type

7.1 Long Acting Insulin

7.1.1 Overview
7.1.2 Long Acting Insulin: Asia-Pacific Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Rapid Acting Insulins

7.2.1 Overview
7.2.2 Rapid Acting Insulins: Asia-Pacific Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Short acting Insulins and Traditional Human Insulins

7.3.1 Overview
7.3.2 Short acting Insulins and Traditional Human Insulins: Asia-Pacific Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Concentrated Insulins and Combination Insulins

7.4.1 Overview
7.4.2 Concentrated Insulins and Combination Insulins: Asia-Pacific Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.5 Biosimilar Insulins

7.5.1 Overview
7.5.2 Biosimilar Insulins: Asia-Pacific Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.6 Glucagon-like peptide-1

7.6.1 Overview
7.6.2 Glucagon-like peptide-1: Asia-Pacific Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.7 Pens and Needles

7.7.1 Overview
7.7.2 Pens and Needles: Asia-Pacific Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia-Pacific Insulin Market – Asia-Pacific Analysis

8.1 Overview

8.2 Asia-Pacific

8.2.1 Asia-Pacific Insulin Market Breakdown, by Key Country, 2023 and 2028 (%)
8.2.1.1 Asia-Pacific Insulin Market – Revenue and Forecast Analysis – by Country
8.2.1.1 China: Asia-Pacific Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.1.1 China: Asia-Pacific Insulin Market Breakdown, by Type

8.2.1.2 India: Asia-Pacific Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.2.1 India: Asia-Pacific Insulin Market Breakdown, by Type

8.2.1.3 Japan: Asia-Pacific Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.3.1 Japan: Asia-Pacific Insulin Market Breakdown, by Type

8.2.1.4 Australia: Asia-Pacific Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.4.1 Australia: Asia-Pacific Insulin Market Breakdown, by Type

8.2.1.5 Rest of Asia-Pacific : Asia-Pacific Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.5.1 Rest of Asia-Pacific : Asia-Pacific Insulin Market Breakdown, by Type

9. Competitive Landscape

9.1 Heat Map Analysis

9.2 Company Positioning and Concentration

10. Industry Landscape

10.1 Overview

10.2 Market Initiative

10.3 Partnerships and Collaborations

10.4 Other Developments

11. Company Profiles

11.1 Adocia

11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments

11.2 Biocon

11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments

11.3 Eli Lilly and Company

11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments

11.4 GlaxoSmithKline plc.

11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

11.5 Merck & Co., Inc.

11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

11.6 Novo Nordisk A/S

11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments

11.7 Pfizer Inc.

11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments

11.8 Sanofi

11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments

11.9 Tonghua Dongbao Pharmaceutical Co., Ltd.

11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

11.10 Wockhardt

11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix

12.1 About Business Market Insights

12.2 List of Abbreviations

Asia-Pacific Insulin Market

Analysis – by Type (Long Acting Insulin, Rapid Acting Insulins, Short acting Insulins and Traditional Human Insulins, Concentrated Insulins and Combination Insulins, Biosimilar Insulins, Glucagon-like peptide-1 (GLP-1), Pens and Needles, and Others)